Abingdon Analytical Laboratory opens at Doncaster

This article was authored by Unknown for www.research-tree.com and published under the title 'Abingdon Health PLC - Abingdon Analytical Laboratory opens at Doncaster on Abingdon Health PLC - Abingdon Analytical Laboratory opens at Doncaster. It is reproduced above in accordance with section 30(2) of the Copyright, Design and Patents Act 1988.

 

The Group has been providing analytical laboratory services since 2023 as part of its strategy to offer a comprehensive CDMO service that supports its customers in bringing products to market. The services of an analytical laboratory make a significant contribution to a product's regulatory technical file, including product stability testing, specificity, sensitivity, assessment of detection limits, interference, cross-reactivity testing, and method comparisons. The technical file is a key requirement for regulatory approval by FDA, EU IVDR, UKCA and other regulatory authorities. Abingdon Analytical Ltd will provide its services for the lateral flow testing market and for adjacent sectors, such as other immunodiagnostic products and molecular diagnostics.

The Group is investing up to £1 million of the proceeds of the recent placing to strengthen its analytical laboratory service, part of which has financed this opening.

Dr Chris Hand, Executive Chairman of Abingdon Health plc, commented: "This next step in our expansion provides a comprehensive analytical services laboratory, forming a bridge between our CDMO and regulatory service offerings, and linking our group companies, Abingdon Health, IVDeology and CS (Life Sciences). The capability to generate analytical and product performance data for use in a product's regulatory technical file adds another element to the broad portfolio of services we offer our customers. The first major contract announced today illustrates the benefit of adding this analytical capability to our CDMO offering."

For more information visit: www.abingdonhealth.com